Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

EHA 2022 presentations describe sickle cell disease headway and headwinds

June 14, 2022

At EHA 2022, insights into multiple reasons for marrow failure

June 13, 2022

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

June 7, 2022

Chinese investigators patent new HIF inhibitors

May 13, 2022

Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants

April 12, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Feb. 28, 2022

Microlyse targets VWF and clears microvascular thrombosis

Feb. 23, 2022

New coagulation factor XIa inhibitors synthesized at Janssen Pharmaceutica

Feb. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...